GSK3B and esophageal squamous cell carcinoma: STAT3 is also a target of GSK3β and GSK3β inhibition reduced STAT3 phosphorylation while higher GSK3β expression promoted esophageal squamous cell carcinoma progression through STAT3 in vitro and in vivo (28).